Department of Pulmonology, Arrazi Hospital, CHU Mohammed VI, LRMS Laboratory, FMPM, UCA, Marrakech, Morocco.
World Journal of Advanced Research and Reviews, 2025, 28(02), 2558-2561
Article DOI: 10.30574/wjarr.2025.28.2.3968
Received 15 October 2025; revised on 26 November 2025; accepted on 29 November 2025
Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease that can affect various organs, including the lungs. Pulmonary vasculitis is a rare but severe manifestation that may acutely reveal SLE. It results from immune-mediated inflammation of pulmonary vessels, potentially leading to severe hypoxemia, respiratory failure, and diffuse parenchymal involvement. We report the case of a 36-year-old woman who presented with pulmonary vasculitis as the first manifestation of SLE, which progressed to acute respiratory distress requiring mechanical ventilation, with diagnosis confirmed by specific immunological markers. Management included intravenous methylprednisolone pulses, followed by oral prednisone and hydroxychloroquine. This case highlights the importance of early recognition of severe pulmonary manifestations of lupus to prevent life-threatening complications.
Systemic Lupus Erythematosus; Pulmonary Vasculitis; Respiratory Failure; Hydroxychloroquine; Methylprednisolone
Get Your e Certificate of Publication using below link
Preview Article PDF
A. Mourhri, S. Moatassime, M. Ijim, O. Fikri and L. Amro. When the lungs reveal the hidden lupus: A case of pulmonary vasculitis as the first manifestation of systemic lupus erythematosus. World Journal of Advanced Research and Reviews, 2025, 28(02), 2558-2561. Article DOI: https://doi.org/10.30574/wjarr.2025.28.2.3968.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0